Ironwood Pharmaceuticals Inc (IRWD) — Strategic Asset Allocation Index
Ironwood Pharmaceuticals Inc (IRWD) has a Strategic Asset Allocation Index of 0.9% as of March 2023. Strategic assets (PP&E of $6.01 Million plus long-term investments of $-) total $6.01 Million, measured against net assets of $706.85 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Ironwood Pharmaceuticals Inc (IRWD) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Ironwood Pharmaceuticals Inc Strategic Asset Allocation Index (2010–2022)
This chart shows how Ironwood Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 11 annual periods from 2010 to 2022. As of March 2023, the index stands at 0.9%, representing strategic assets of $6.01 Million against net assets of $706.85 Million USD. For live market cap and overall valuation, see IRWD stock market capitalisation.
Annual Strategic Asset Allocation Index for Ironwood Pharmaceuticals Inc (2010–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Ironwood Pharmaceuticals Inc from 2010 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Ironwood Pharmaceuticals Inc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.2% | $20.88 Million | $6.29 Million | $14.59 Million | $652.38 Million | ▼ -4.5 pp |
| 2021 | 7.7% | $46.92 Million | $22.93 Million | $24.00 Million | $605.91 Million | ▼ -64.7 pp |
| 2020 | 72.5% | $45.40 Million | $8.93 Million | $36.47 Million | $62.64 Million | ▼ -1201.5 pp |
| 2017 | 1274.0% | $125.46 Million | $17.27 Million | $108.19 Million | $9.85 Million | ▲ +1044.6 pp |
| 2016 | 229.4% | $153.03 Million | $20.51 Million | $132.52 Million | $66.72 Million | ▲ +116.3 pp |
| 2015 | 113.1% | $107.54 Million | $21.07 Million | $86.47 Million | $95.12 Million | ▲ +79.4 pp |
| 2014 | 33.7% | $29.83 Million | $29.83 Million | $- | $88.55 Million | ▼ -64.1 pp |
| 2013 | 97.8% | $37.38 Million | $37.38 Million | $- | $38.23 Million | ▲ +71.7 pp |
| 2012 | 26.1% | $37.54 Million | $37.54 Million | $- | $144.05 Million | ▼ -4.6 pp |
| 2011 | 30.6% | $33.62 Million | $33.62 Million | $- | $109.86 Million | ▲ +9.1 pp |
| 2010 | 21.5% | $34.37 Million | $34.37 Million | $- | $159.55 Million | — |